Alcohol Research Consortium in HIV: Administrative Core

艾滋病毒酒精研究联盟:行政核心

基本信息

  • 批准号:
    10304372
  • 负责人:
  • 金额:
    $ 14.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-10 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

This program project application for the Alcohol Research Consortium on HIV (ARCH)* builds on and extends our very successful administrative and research accomplishments over the past 9 years of NIAAA support. Combining expertise and experience across disciplines and Universities, the ARCH consortium consists of the Administrative Core (ARCH-AC), the Biostatistics/Methods Core (ARCH-BMC), the epidemiological research component (ARCH- ERA) and the implementation research component (ARCH-IRA) and the relapse prevention research component (ARCH-RPA). The ARCH Administrative Core (ARCH-AC) provides the infrastructure for oversight, coordination and direction to these program project components, and facilitates the overarching P01 scientific goals as well as the project aims of ARCH cores and components. ARCH-AC builds on the administrative structure established during our previous funding periods, and includes: a Steering Committee (chaired by the ARCH-AC MPIs and including the Project Leads of the BMC and three research components); Component Working Committees (chaired by the component Project Lead(s) with participation by component faculty, staff and mentees, and participation by AC and BMC staff as appropriate/needed), and the Program Advisory Committee (PAC), an outstanding, already established board of advisors with national and international expertise in HIV, clinical cohorts, epidemiology, psychology, implementation research, alcohol use disorder. In addition to coordinating and documenting a regular meeting schedule across the different committees, ARCH-AC also uses multiple well-established administrative processes for monitoring project milestones and quality control, overseeing resource allocation and coordination, ensuring regulatory compliance, mentoring students and junior faculty, and disseminating new knowledge through publications, presentations and a project website. ARCH-AC is led by national experts in alcohol and HIV research and services, who have combined experience in conducting epidemiologic and clinical research in HIV/AIDS and alcohol use. The ARCH-AC MPIs have primary responsibility for maintaining communication and collaborative relationships with external organizations including CNICS, JHU and US CFARs, NIAAA and other program projects funded under this announcement. ARCH-AC synergizes the proposed epidemiological and intervention research critical to address NIH and End the HIV Epidemic priorities.
该计划项目申请酒精研究联盟对艾滋病毒(艾滋病)* 建立 在过去我们非常成功的行政和研究成就的基础上, 9年的NIAAA支持。结合跨学科的专业知识和经验, 大学,该联盟由行政核心(ARCH-AC), 生物统计学/方法核心(ARCH-BMC),流行病学研究部分(ARCH-BMC), ERA)和实施研究部分(ARCH-IRA)以及复发预防 研究组件(ARCH-RPA)。ARCH-AC(英语:ARCH-AC)提供 监督、协调和指导这些规划项目组成部分基础设施, 并促进了总体P01科学目标以及项目目标的核心 和组件。ARCH-AC建立在我们在 包括:指导委员会(由ARCH-AC MPI主持 并包括BMC的项目负责人和三个研究组成部分);组成部分 工作委员会(由项目负责人主持, 组成教师,工作人员和学员,以及AC和BMC工作人员的参与, (1)项目咨询委员会(PAC),一个杰出的,已经 建立了具有艾滋病毒、临床队列、 流行病学,心理学,实施研究,酒精使用障碍。除了 协调和记录不同委员会的定期会议时间表, ARCH-AC还使用多个完善的管理流程来监控项目 里程碑和质量控制,监督资源分配和协调,确保 监管合规,指导学生和初级教师,并传播新知识 通过出版物、介绍和项目网站。ARCH-AC由国家专家领导 在酒精和艾滋病毒的研究和服务,谁结合经验,进行 艾滋病毒/艾滋病和酗酒的流行病学和临床研究。ARCH-AC MPI具有 主要负责与以下人员保持沟通和协作关系 外部组织,包括CNICS、JHU和US CFAR、NIAAA和其他计划 根据本公告资助的项目。ARCH-AC协同拟议的流行病学 和干预研究对解决NIH和结束艾滋病毒流行的优先事项至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEETANJALI CHANDER其他文献

GEETANJALI CHANDER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEETANJALI CHANDER', 18)}}的其他基金

HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS
艾滋病毒和药物使用队列协调中心新兴和高影响科学跨队列研究:艾滋病毒成功
  • 批准号:
    10676432
  • 财政年份:
    2023
  • 资助金额:
    $ 14.68万
  • 项目类别:
Training in Equity and Structural Solutions in Addictions (TESSA)
成瘾公平和结构性解决方案培训(TESSA)
  • 批准号:
    10625735
  • 财政年份:
    2023
  • 资助金额:
    $ 14.68万
  • 项目类别:
Mentoring and Patient Oriented Research at the Nexus of Unhealthy Alcohol Use and HIV
不健康饮酒与艾滋病毒关系的指导和以患者为导向的研究
  • 批准号:
    10608555
  • 财政年份:
    2022
  • 资助金额:
    $ 14.68万
  • 项目类别:
Mentoring and Patient Oriented Research at the Nexus of Unhealthy Alcohol Use and HIV
不健康饮酒与艾滋病毒关系的指导和以患者为导向的研究
  • 批准号:
    10685992
  • 财政年份:
    2022
  • 资助金额:
    $ 14.68万
  • 项目类别:
Alcohol Research Consortium in HIV: Implementation Research Arm
艾滋病毒酒精研究联盟:实施研究部门
  • 批准号:
    10304375
  • 财政年份:
    2021
  • 资助金额:
    $ 14.68万
  • 项目类别:
Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua
艾滋病毒酒精研究联盟:通过酒精和艾滋病毒护理交叉点的干预措施和流行病学结束艾滋病毒流行 Continua
  • 批准号:
    10304371
  • 财政年份:
    2021
  • 资助金额:
    $ 14.68万
  • 项目类别:
Impact of alcohol reduction on Tuberculosis drug levels, TB adherence and gut microbiome
减少饮酒对结核病药物水平、结核病依从性和肠道微生物群的影响
  • 批准号:
    10544859
  • 财政年份:
    2020
  • 资助金额:
    $ 14.68万
  • 项目类别:
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
印度结核病和艾滋病毒感染者减少饮酒的混合试验 (HATHI)
  • 批准号:
    10658901
  • 财政年份:
    2020
  • 资助金额:
    $ 14.68万
  • 项目类别:
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
印度结核病和艾滋病毒感染者减少饮酒的混合试验 (HATHI)
  • 批准号:
    10252751
  • 财政年份:
    2020
  • 资助金额:
    $ 14.68万
  • 项目类别:
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
印度结核病和艾滋病毒感染者减少饮酒的混合试验 (HATHI)
  • 批准号:
    10435573
  • 财政年份:
    2020
  • 资助金额:
    $ 14.68万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 14.68万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 14.68万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 14.68万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 14.68万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 14.68万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 14.68万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 14.68万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 14.68万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 14.68万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 14.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了